Skip to main content

Abstract

In this chapter, the pharmacological factors involved in predicting the abuse liability of drugs are discussed with major emphasis on their psychological dependence potential. For prediction of drug abuse liability, it is important to find and compare the drug’s effects against those of prototypic drugs. The important pharmacological properties include the following: central nervous system (CNS) effects, including operant behavioral effects; tolerance; physical dependence potential; and psychological dependence potential. It is also important to consider such chemical and pharmacokinetic properties as water solubility and speeds of absorption and elimination. In particular, psychological dependence potential is most relevant to abuse liability. To evaluate psychological dependence potential from animal studies, the reinforcing and discriminative stimulus properties of drugs must be assessed in comparison with those of prototypic drugs. When human data are available, it is important to verify the animal results on such points as pharmacokinetics and CNS drug susceptibility which may differ across species.

Special consideration should also be given to the following in evaluating psychological dependence potential from animal studies: differences in reinforcing effects depending on the experimental procedure used, analysis of reinforcement data obtained in intragastric self-administration, daily dose and CNS manifestation in self-administration experiments, and influence of physical dependence. From a practical viewpoint, it is also important to predict the nature and extent of ill effects which arise as a consequence of abuse. For this, such drug properties as the CNS effects, psychological dependence potential, toxicity, tolerance, and physical dependence potential must be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Brady, J. V., & Griffiths, R. R. (1983). Testing drugs for abuse liability and behavioral toxicity: Progress report from the laboratories at the Johns Hopkins University School of Medicine. In L. S. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 43, pp. 99–124). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Deneau, G., Yanagita, T., & Seevers, M. H. (1969). Self-administration of psychoactive substances by the monkey: A measure of psychological dependence. Psychopharmacologia, 16, 30–48.

    Article  PubMed  CAS  Google Scholar 

  • United Nations (1977). Convention on psychotropic substances, 1971. New York: United Nations.

    Google Scholar 

  • WHO Expert Committee on Drug Dependence. (1969). World Health Organization technical report series (No. 407).

    Google Scholar 

  • Yanagita, T. (1976). Some methodological problems in assessing dependence-producing properties of drugs in animals. Pharmacological Reviews, 27, 503–509.

    Google Scholar 

  • Yanagita, T. (1977). Brief review on the use of self-administration techniques for predicting drug dependence potential. In T. Thompson & K. R. Unna (Eds.), Predicting dependence liability of stimulant and depressant drugs (pp. 231–242). Baltimore: University Park Press.

    Google Scholar 

  • Yanagita, T., Ando, K., Kato, S., & Takada, K. (1983). Psychopharmacological studies on nicotine and tobacco smoking in rhesus monkeys. Psychopharmacology Bulletin, 19(3), 409–412.

    PubMed  CAS  Google Scholar 

  • Yanagita, T., Ando, K., Oinuma, N., & Ishida, K. (1974). Intravenous self-administration of nicotine and an attempt to produce smoking behavior in monkeys. Committee on Problems of Drug Dependence, 567–578.

    Google Scholar 

  • Yanagita, T., & Kato, S., (1983). Dependence studies on zopiclone. In L. S. Harris (Ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 43, pp. 164–170). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Yanagita, T., Miyasato, K., & Sato, J. (1980). Dependence potential of loperamide studied in rhesus monkeys. In L. S. Harris (Ed.), Problems of drug dependence, 1979 (National Institute on Drug Abuse Research Monograph 27, pp. 106–113). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Yanagita, T. (1987). Prediction of Drug Abuse Liability from Animal Studies. In: Bozarth, M.A. (eds) Methods of Assessing the Reinforcing Properties of Abused Drugs. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4812-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4812-5_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9163-3

  • Online ISBN: 978-1-4612-4812-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics